Kim K Y, Choi I, Kim S S
Protein Laboratory, Mogam Biotechnology Research Institute, Kyonggi-Do, Korea.
J Biochem. 2000 Jan;127(1):23-7. doi: 10.1093/oxfordjournals.jbchem.a022579.
An inhibitor of the proliferation of hepatic stellate cells (HSC) was purified from rat liver by a combination of gel filtration and ion exchange chromatography. The molecular mass of this non-arginase growth inhibitory factor (NAGIF) was determined to be 38 kDa by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and gel filtration. The proliferation of HSC was inhibited by NAGIF with a 50% inhibitory dose of 5 nmol/liter. The inhibitory activity of NAGIF was not limited to HSC but also affected the growth of bovine endothelial cells and 3T6 fibroblasts. However, the growth of B16 mouse melanoma was not inhibited by NAGIF. The NH(2)-terminal sequence of NAGIF, AEPVEPWS, is identical to an internal sequence of rat Zn-alpha(2)-glycoprotein. Although the action mode of this inhibitor remains to be investigated, it seems very likely that NAGIF is involved in the negative control mechanism of HSC growth.
通过凝胶过滤和离子交换色谱相结合的方法,从大鼠肝脏中纯化出一种肝星状细胞(HSC)增殖抑制剂。通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳和凝胶过滤测定,这种非精氨酸酶生长抑制因子(NAGIF)的分子量为38 kDa。NAGIF抑制HSC增殖,其50%抑制剂量为5 nmol/升。NAGIF的抑制活性不仅限于HSC,还影响牛内皮细胞和3T6成纤维细胞的生长。然而,NAGIF不抑制B16小鼠黑色素瘤的生长。NAGIF的NH(2)-末端序列AEPVEPWS与大鼠锌-α(2)-糖蛋白的内部序列相同。尽管这种抑制剂的作用模式仍有待研究,但NAGIF很可能参与了HSC生长的负调控机制。